Clinical Pharmacokinetics and Pharmacodynamics of Anti-Tubercular Drugs in Pregnancy.

European Journal of Drug Metabolism and Pharmacokinetics
Jennifer R ShiuTony K L Kiang

Abstract

The objectives of this qualitative review were to critically evaluate and summarize the currently available data on the use of anti-tuberculosis (TB) drugs during pregnancy, with a focus on treatment outcomes, safety, and pharmacokinetics. This qualitative, narrative review was based on literature searches in Medline, Pubmed, Embase, and Google Scholar (from their inception to 13 August 2020). Our search identified 22 papers related to treatment outcomes and 14 papers related to pharmacokinetic exposures and fetal distributions. While it is challenging to study this patient population, current evidence supports treatment of drug-susceptible TB, multidrug-resistant TB and latent TB infections. However, decisions regarding initiating, continuing, or discontinuing anti-tubercular medications while pregnant should be individualized and discussed with a specialist. Similarly, the pharmacokinetic data of anti-TB agents were mainly derived from small scale, observational studies many of which lacked high quality controls. Based on these data, it does not appear that pregnancy has an extensive impact on the pharmacokinetics of the majority of first-line and second-line agents, although caution (discussed in the review) should be exerci...Continue Reading

References

Jul 2, 1977·Lancet·I Rocker
Sep 1, 1979·Tubercle·J M Shneerson, R S Francis
Jun 1, 1977·The Journal of Infectious Diseases·B BernardP F Wehrle
Jan 1, 1977·The Journal of International Medical Research·F Flores-MercadoC Diaz-Gonzales
Nov 30, 1989·The American Journal of Medicine·H GiamarellouP Sfikakis
Jun 1, 1974·Clinical Pharmacology and Therapeutics·J T ClarkeW M Kirby
Aug 18, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A T Nitta, D Milligan
Jul 11, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·G Bothamley
Mar 12, 2003·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·S N Tripathy, S N Tripathy
Mar 12, 2003·Chest·Klaus-Dieter K L Lessnau, Samer Qarah
Apr 10, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sonya ShinJennifer Furin
Sep 1, 1955·Gynaecologia. International Monthly Review of Obstetrics and Gynecology. Revue Internationale Mensuelle D'obstétrique Et De Gynécologie. Monatsschrift Für Geburtshilfe Und Gynäkologie·Y M BROMBERGI BRUDERMAN
Apr 14, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Eda PalaciosSonya Shin
Apr 27, 2010·International Journal of Antimicrobial Agents·Ozgur OzyuncuM Sinan Beksac
May 4, 2010·Clinical Obstetrics and Gynecology·Chia-Ling Nhan-Chang, Theodore B Jones
Jul 6, 2010·The Journal of Obstetrics and Gynaecology Research·Ozgür OzyüncüSedef Kir
Nov 19, 2010·BJOG : an International Journal of Obstetrics and Gynaecology·C N Mnyani, J A McIntyre
Jan 15, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Patricia L ToroAndrea A Howard
Mar 15, 2011·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·P TabarsiA Velayati
Mar 28, 2013·Infectious Diseases in Obstetrics and Gynecology·Allan W TaylorTaraz Samandari
May 1, 2013·Antimicrobial Agents and Chemotherapy·Alma TostmannRob E Aarnoutse
Mar 27, 2015·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Matthew BatesAlimuddin Zumla
Aug 8, 2015·Antimicrobial Agents and Chemotherapy·J J van OosterhoutS Ward
Mar 24, 2016·Case Reports in Obstetrics and Gynecology·Minakshi RohillaG R V Prasad
Apr 16, 2016·Clinical Pharmacology and Therapeutics·Yasar TasnifMary F Hebert
Aug 16, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Payam NahidAndrew Vernon
Aug 10, 2017·Emerging Infectious Diseases·Marie JaspardEric Caumes
Feb 3, 2018·Annals of the American Thoracic Society·Ruth N MoroTimothy R Sterling
Oct 3, 2019·The New England Journal of Medicine·Amita GuptaUNKNOWN IMPAACT P1078 TB APPRISE Study Team
Nov 16, 2019·American Journal of Respiratory and Critical Care Medicine·Payam NahidBarbara Seaworth
Dec 18, 2019·Antimicrobial Agents and Chemotherapy·Mahmoud Tareq AbdelwahabPaolo Denti
Mar 19, 2020·The New England Journal of Medicine·Thierry TiendrebeogoRenaud Becquet
Mar 19, 2020·The New England Journal of Medicine·Amita GuptaGerhard Theron

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy
acetylation
acetylator

Software Mentioned

TEMPRANO
Google Scholar
iAdhere
Embase

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Related Papers

Indian Journal of Pediatrics
Geetha RamachandranSoumya Swaminathan
Expert Opinion on Drug Metabolism & Toxicology
Mahendra ShuklaJawahar Lal
© 2021 Meta ULC. All rights reserved